Probiotic Formula and Infant Growth

NCT ID: NCT01476397

Last Updated: 2014-11-04

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Study Classification

INTERVENTIONAL

Study Start Date

2011-12-31

Study Completion Date

2013-10-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This is a growth study of full-term, formula-fed infants randomized to receive a partially hydrolyzed whey protein formula with and without probiotics for the first four months of life. It is hypothesized that there will be no difference in growth between the two groups.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Healthy

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

control infant formula

partially hydrolyzed whey infant formula

Group Type ACTIVE_COMPARATOR

Control infant formula

Intervention Type OTHER

partially hydrolyzed whey infant formula consumed ad libitum throughout study

test infant formula

partially hydrolyzed whey infant formula with probiotic

Group Type EXPERIMENTAL

Test infant formula

Intervention Type OTHER

partially hydrolyzed whey formula with probiotic

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Control infant formula

partially hydrolyzed whey infant formula consumed ad libitum throughout study

Intervention Type OTHER

Test infant formula

partially hydrolyzed whey formula with probiotic

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Healthy newborn infant
* Full-term
* Birth weight \> 2500 and \< 4500 g
* 14±3 days of age on enrollment
* Exclusively formula-fed, singleton birth
* Having obtained his/her legal representative's informed consent

Exclusion Criteria

* Known or suspected cow-milk allergy
* Congenital illness or malformation that may affect infant feeding and/or growth
* Significant prenatal and/or postnatal disease
* Any readmission to hospital prior to enrollment
* Receiving prescription medication or frequent use of over the counter medications except vitamin and mineral supplements
* Has received intravenous antibiotic therapy or oral probiotic in the last 7 days
* Currently participating in another clinical study
* Cannot be expected to comply with treatment
Minimum Eligible Age

11 Days

Maximum Eligible Age

17 Days

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Société des Produits Nestlé (SPN)

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

North Scottsdale Pediatric Associates

Scottsdale, Arizona, United States

Site Status

Pediatrics & Adolescent Medicine

Marietta, Georgia, United States

Site Status

Kentucky Pediatric Adult Research

Bardstown, Kentucky, United States

Site Status

PMG Research of Winston-Salem

Winston-Salem, North Carolina, United States

Site Status

Medical University of South Carolina

Charleston, South Carolina, United States

Site Status

PMG Research of Bristol

Bristol, Tennessee, United States

Site Status

Pediatric Healthcare of Northwest Houston

Tomball, Texas, United States

Site Status

Advanced Pediatrics

Vienna, Virginia, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

10.01.US.INF

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Starter Infant Formula With Synbiotics
NCT06073652 ACTIVE_NOT_RECRUITING NA
Prebiotic in Preterm Infants
NCT03306316 COMPLETED NA
Efficacy of a Dietary Supplement in Infants
NCT07341477 NOT_YET_RECRUITING NA
Preterm Infant Growth
NCT01162798 COMPLETED NA